Clinical trial discovery
Find Clinical Trials
Search studies by condition, treatment, location, eligibility, or trial identifier.
Showing 1–12 of 12 trials
Active filters
Clinical trials found
Published and searchable clinical trials
NCT06477419
- Conditions
- Adenoma, Lung Diseases, Lung Neoplasms, +13 more
- Locations
-
- Memorial Sloan Kettering Basking Ridge Basking Ridge, New Jersey, United States
- Memorial Sloan Kettering Monmouth Middletown, New Jersey, United States
- Memorial Sloan Kettering Bergen Montvale, New Jersey, United States
- Memorial Sloan Kettering Cancer Center @ Commack Commack, New York, United States
NCT07126509
- Conditions
- Adenoma, Lung Diseases, Lung Neoplasms, +14 more
- Locations
-
- University of Chicago Medicine Comprehensive Cancer Center Chicago, Illinois, United States
NCT03760575
- Conditions
- Adenoma, Lung Diseases, Lung Neoplasms, +12 more
- Locations
-
- Abramson Cancer Center of the University of Pennsylvania Philadelphia, Pennsylvania, United States
The IMmunotherapy Pleural 5-ALA PDT
NCT04400539
- Conditions
- Adenoma, Lung Diseases, Lung Neoplasms, +13 more
- Locations
-
- Institut Coeur-Poumon, CHU Lille, France
NCT06581549
- Conditions
- Adenoma, Lung Diseases, Lung Neoplasms, +13 more
- Locations
-
- Istituto Clinico Humanitas Rozzano, Milano, Italy
- Centro di Riferimento Oncologico (CRO) IRCCS Aviano, Pordenone, Italy
- Azienda Ospedaliera SS Antonio e Biagio e Cesare Arrigo Alessandria, Italy
- Asst Papa Giovanni Xxiii Bergamo Bergamo, Italy
NCT05304208
- Conditions
- Adenoma, Lung Diseases, Lung Neoplasms, +12 more
- Locations
-
- Erasmus MC Rotterdam, South Holland, Netherlands
Atezolizumab Versus Placebo for the Adjuvant Treatment of Malignant Pleural Mesothelioma (Atezomeso)
NCT04996017
- Conditions
- Adenoma, Lung Diseases, Lung Neoplasms, +12 more
- Locations
-
- Istituto Scientifico Romagnolo Per Lo Studio E La Cura Dei Tumori - Irccs Meldola, ITAòY, Italy
- Ospedaliera SS Antonio e Biagio e Cesare Arrigo di Alessandria Alessandria, Italy
- Istituto Tumori Bari Bari, Italy
- Azienda Ospedaliera Universitaria Policlinico- Vittorio Emanuele Catania Catania, Italy
NCT05278975
- Conditions
- Adenoma, Lung Diseases, Lung Neoplasms, +18 more
- Locations
-
- South Mead North Bristol Hopsital Bristol, United Kingdom
- Leeds Teaching Hospital Leeds, United Kingdom
- Northumbria NorthTyne Side General Hospital North Shields, United Kingdom
- NHS Greater Glasgow & Clyde Glasgow, United Kingdom
NCT03054298
- Conditions
- Adenocarcinoma, Adenocarcinoma of Lung, Adenoma, +35 more
- Locations
-
- University of Pennsylvania Philadelphia, Pennsylvania, United States
Phase 1/2 Trial of Gavo-cel (TC-210) in Patients With Advanced Mesothelin-Expressing Cancer
NCT03907852
- Conditions
- Adenocarcinoma, Adenoma, Adnexal Diseases, +38 more
- Locations
-
- University of California, San Francisco San Francisco, California, United States
- University of Miami Sylvester Cancer Center Miami, Florida, United States
- University of Chicago Medical Center Chicago, Illinois, United States
- National Cancer Institute Bethesda, Maryland, United States
Pembrolizumab Plus Lenvatinib In Second Line and Third Line Malignant Pleural mesotheLioma Patients
NCT04287829
- Conditions
- Adenoma, Lung Diseases, Lung Neoplasms, +12 more
- Locations
-
- Antoni van Leeuwenhoekziekenhuis (NKI-AVL) Amsterdam, North Holland, Netherlands
Nivolumab and Ipilimumab +/- UV1 Vaccination as Second Line Treatment in Patients With Malignant Mesothelioma
NCT04300244
- Conditions
- Adenoma, Cancer, Cancer of Lung, +17 more
- Locations
-
- University of Western Australia Perth, Australia
- Aalborg University Hospital Aalborg, Denmark
- Copenhagen University Hospital Copenhagen, Denmark
- Oslo University Hospital Oslo, Norway